🇺🇸 FDA
Pipeline program

Azilsartan medoxomil and chlorthalidone

TAK-491CLD_301

Phase 3 small_molecule completed

Quick answer

Azilsartan medoxomil and chlorthalidone for Essential Hypertension is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 4 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Essential Hypertension
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials